Treatment of inflammatory diseases by inhibiting cold-inducible RNA-binding protein (CIRP)
US8703138B2 · kind B2 · utility
2Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 13, 2010 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | Apr 13, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are pharmaceutical compositions comprising a CIRP inhibitor. A method of treating a subject suffering from an inflammatory condition comprising administering to said subject a CIRP inhibitor is also described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.